Capstone Investment Advisors LLC Invests $208,000 in Sotera Health (NASDAQ:SHC)

Capstone Investment Advisors LLC acquired a new position in shares of Sotera Health (NASDAQ:SHCFree Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 12,319 shares of the company’s stock, valued at approximately $208,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. DekaBank Deutsche Girozentrale bought a new position in shares of Sotera Health in the third quarter valued at approximately $58,000. Quest Partners LLC bought a new position in shares of Sotera Health in the fourth quarter valued at approximately $139,000. Allegheny Financial Group LTD acquired a new stake in shares of Sotera Health in the fourth quarter valued at approximately $177,000. Pinkerton Retirement Specialists LLC acquired a new stake in shares of Sotera Health in the third quarter valued at approximately $220,000. Finally, Aigen Investment Management LP acquired a new stake in shares of Sotera Health in the fourth quarter valued at approximately $243,000. 91.03% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

SHC has been the subject of a number of research reports. Citigroup raised shares of Sotera Health from a “neutral” rating to a “buy” rating and lowered their price target for the company from $18.00 to $16.00 in a report on Wednesday, April 3rd. Royal Bank of Canada reissued an “outperform” rating and issued a $20.00 price target on shares of Sotera Health in a report on Monday, March 4th. TheStreet raised shares of Sotera Health from a “d” rating to a “c-” rating in a report on Tuesday, February 27th. Barclays lowered their price target on shares of Sotera Health from $19.00 to $14.00 and set an “overweight” rating for the company in a report on Wednesday, April 10th. Finally, Piper Sandler started coverage on shares of Sotera Health in a report on Tuesday, May 21st. They set a “neutral” rating and a $13.00 target price for the company. Two analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $16.92.

Check Out Our Latest Report on SHC

Sotera Health Price Performance

Shares of SHC stock opened at $11.46 on Tuesday. Sotera Health has a 12-month low of $10.71 and a 12-month high of $19.40. The firm has a market capitalization of $3.24 billion, a price-to-earnings ratio of 60.32 and a beta of 2.05. The company has a quick ratio of 2.86, a current ratio of 3.20 and a debt-to-equity ratio of 5.39. The firm has a fifty day moving average of $11.29 and a 200-day moving average of $13.73.

Sotera Health (NASDAQ:SHCGet Free Report) last posted its quarterly earnings data on Thursday, May 2nd. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.01). The company had revenue of $248.18 million during the quarter, compared to the consensus estimate of $254.73 million. Sotera Health had a net margin of 5.09% and a return on equity of 48.47%. On average, equities research analysts forecast that Sotera Health will post 0.63 earnings per share for the current year.

About Sotera Health

(Free Report)

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

See Also

Institutional Ownership by Quarter for Sotera Health (NASDAQ:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.